SIRT4 and neoplasm: As SIRT4-repressed glutaminolysis inhibited cancer cell growth,25, 26 our elucidation that SIRT4 acts as a target gene of CtBP further strongly supports the view that CtBP can be a potential target of tumor therapeutic strategy.